Citation Impact
Citing Papers
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801
1993
Dissociable Effects of Antagonism of NMDA and AMPA/KA Receptors in the Nucleus Accumbens Core and Shell on Cocaine-seeking Behavior
2001
Femtomolar Concentrations of Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against Inflammatory Damage
2001
Investigations of Temperament at Three to Seven Years: The Children's Behavior Questionnaire
2001 Standout
Glutamate receptor ion channels
2005 Standout
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
1997
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Effects of putative cognitive function-enhancing drugs and dopaminergic agents on somatostatin and neuropeptide Y in rat brain
1993
Prospects of glutamate antagonists in the therapy of Parkinson's disease
1998
Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)
1993
Dopamine D1 Receptor‐mediated Facilitation of GABAergic Neurotransmission in the Rat Strioentopeduncular Pathway and its Modulation by Adenosine A1 Receptor‐mediated Mechanisms
1996
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats
1999
The nucleus accumbens as a complex of functionally distinct neuronal ensembles: An integration of behavioural, electrophysiological and anatomical data
1994
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Structure-Guided Directed Evolution of Highly Selective P450-Based Magnetic Resonance Imaging Sensors for Dopamine and Serotonin
2012 StandoutNobel
Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion
1999
Glutamatergic control over brain dopamine release in vivo and in vitro
1997
The adolescent brain and age-related behavioral manifestations
2000 Standout
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Rationale for and use of NMDA receptor antagonists in Parkinson's disease
2004
Parkinson's disease
2009 Standout
A trial of dextromethorphan in parkinsonian patients with motor response complications
1998
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
Mitochondria: In Sickness and in Health
2012 Standout
What makes us tick? Functional and neural mechanisms of interval timing
2005 Standout
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
1993
From mice to men: What can we learn about personality from animal research?
2001 Standout
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Multipoint analysis of reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism
2009
Parkinson's Disease: Past, Present, and Future
1993
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases
2004
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Intravenous amantadine improves levadopa‐induced dyskinesias: An acute double‐blind placebo‐controlled study
2001
The Adolescent Brain
2008 Standout
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice
1992 StandoutNobel
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats
1995
Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione
1998
Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice
1999 StandoutNobel
Non-motor features of Parkinson disease
2017 Standout
Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice
1991
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Neurodegenerative diseases and oxidative stress
2004 Standout
The variable nature of cognitive control: a dual mechanisms framework
2012 Standout
Nondopaminergic mechanisms in levodopa‐induced dyskinesia
2005
Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse
2003
The molecular neurobiology of depression
2008 StandoutNature
Estrogen Actions in the Central Nervous System1
1999 Standout
Neurocircuitry of Addiction
2009 Standout
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
1994
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
1998
Parkinson's Disease
2003 Standout
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium
1986
D1–D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression
1995
Neostriatal mechanisms in Parkinson's disease
1998
Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane
2001
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
1993
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum
1996
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
1985
Emerging Targets in Photopharmacology
2016 StandoutNobel
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
1998
Levodopa therapy
1998
Amantadine for dyskinesia in Parkinson's disease
2003
Dopamine Receptors: From Structure to Function
1998 Standout
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
1985
Both Protein Kinase A and Mitogen-Activated Protein Kinase Are Required in the Amygdala for the Macromolecular Synthesis-Dependent Late Phase of Long-Term Potentiation
2000 StandoutNobel
Works of Robert C. Boldry being referenced
The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of ?-aspartic acid into the nucleus accumbens
1988
Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade
1995
Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin
1992
Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions
1992
The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA
1991
Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists
1993
NMDA receptor blockade reverses motor response alterations induced by levodopa
1994
N-methyl-d-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion
1993
Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging
1992
Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart
1984